Predicting Individualized Lung Disease Progression in Treatment-Naive Patients With Lymphangioleiomyomatosis

医学 DLCO公司 淋巴管平滑肌瘤病 扩散能力 自然史 队列 内科学 肺移植 间质性肺病 队列研究 肺功能 肿瘤科
作者
Anushka Palipana,Emrah Gecili,Seongho Song,Simon R. Johnson,Rhonda D. Szczesniak,Nishant Gupta
出处
期刊:Chest [Elsevier BV]
卷期号:163 (6): 1458-1470 被引量:9
标识
DOI:10.1016/j.chest.2022.12.027
摘要

Lung function decline varies significantly in patients with lymphangioleiomyomatosis (LAM), impeding individualized clinical decision-making.Can we aid individualized decision-making in LAM by developing a dynamic prediction model that can estimate the probability of clinically relevant FEV1 decline in patients with LAM before treatment initiation?Patients observed in the US National Heart, Lung, and Blood Institute (NHLBI) Lymphangioleiomyomatosis Registry were included. Using routinely available variables such as age at diagnosis, menopausal status, and baseline lung function (FEV1 and diffusing capacity of the lungs for carbon monoxide [Dlco]), we used novel stochastic modeling and evaluated predictive probabilities for clinically relevant drops in FEV1. We formed predictive probabilities of transplant-free survival by jointly modeling longitudinal FEV1 and lung transplantation or death events. External validation used the UK Lymphangioleiomyomatosis Natural History cohort.Analysis of the NHLBI Lymphangioleiomyomatosis Registry and UK Lymphangioleiomyomatosis Natural History cohorts consisted of 216 and 185 individuals, respectively. We derived a joint model that accurately estimated the risk of future lung function decline and 5-year probabilities of transplant-free survival in patients with LAM not taking sirolimus (area under the receiver operating characteristic curve [AUC], approximately 0.80). The prediction model provided estimates of forecasted FEV1, rate of FEV1 decline, and probabilities for risk of prolonged drops in FEV1 for untreated patients with LAM with a high degree of accuracy (AUC > 0.80) for the derivation cohort as well as the validation cohort. Our tool is freely accessible at: https://anushkapalipana.shinyapps.io/testapp_v2/.Longitudinal modeling of routine clinical data can allow individualized LAM prognostication and assist in decision-making regarding the timing of treatment initiation.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小鲨鱼完成签到,获得积分10
刚刚
王雨发布了新的文献求助10
1秒前
六六发布了新的文献求助10
1秒前
cobo完成签到,获得积分10
1秒前
牛奶糖完成签到,获得积分10
1秒前
2秒前
跳跃发布了新的文献求助10
2秒前
李禾和完成签到,获得积分10
2秒前
上官若男应助樱花落雨采纳,获得30
2秒前
大笨猪whr发布了新的文献求助10
3秒前
robin完成签到,获得积分10
3秒前
lumen发布了新的文献求助10
3秒前
3秒前
哈ha完成签到 ,获得积分10
3秒前
无言发布了新的文献求助10
3秒前
4秒前
kevinjy完成签到,获得积分0
4秒前
顾矜应助害怕的枫叶采纳,获得10
5秒前
zzzzlll发布了新的文献求助10
5秒前
5秒前
所所应助202000采纳,获得10
5秒前
叶豪完成签到,获得积分10
5秒前
思辰。发布了新的文献求助10
5秒前
看文献了发布了新的文献求助10
6秒前
6秒前
wanci应助懒大王采纳,获得10
6秒前
拥抱黑暗吧完成签到,获得积分10
7秒前
robin发布了新的文献求助10
7秒前
眼睛大的靖仇完成签到,获得积分10
7秒前
7秒前
木禾木完成签到,获得积分10
7秒前
tom完成签到,获得积分10
7秒前
7秒前
molihuakai应助舒心幻竹采纳,获得10
7秒前
单纯书蝶完成签到,获得积分10
7秒前
8秒前
8秒前
8秒前
8秒前
aa发布了新的文献求助10
9秒前
高分求助中
Principles of Economics, 11th Edition 10000
University Physics with Modern Physics, 16th edition 10000
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Matrix Methods in Data Mining and Pattern Recognition 510
Social Skills Improvement System-Rating Scales--Chinese Version 500
Dynamische Polarisation von H-1 und B-11 in (CH-3)-3NBH-3 500
CLSI M07 2024 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 内科学 物理 复合材料 催化作用 细胞生物学 无机化学 光电子学 物理化学 电极 基因
热门帖子
关注 科研通微信公众号,转发送积分 7248259
求助须知:如何正确求助?哪些是违规求助? 8871241
关于积分的说明 18716138
捐赠科研通 6927273
什么是DOI,文献DOI怎么找? 3198269
关于科研通互助平台的介绍 2373861
邀请新用户注册赠送积分活动 2173014